399 related articles for article (PubMed ID: 31551515)
1. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling.
Unamuno X; Gómez-Ambrosi J; Ramírez B; Rodríguez A; Becerril S; Valentí V; Moncada R; Silva C; Salvador J; Frühbeck G; Catalán V
Cell Mol Immunol; 2021 Apr; 18(4):1045-1057. PubMed ID: 31551515
[TBL] [Abstract][Full Text] [Related]
2. Calcium-sensing receptor activates the NLRP3 inflammasome in LS14 preadipocytes mediated by ERK1/2 signaling.
D'Espessailles A; Mora YA; Fuentes C; Cifuentes M
J Cell Physiol; 2018 Aug; 233(8):6232-6240. PubMed ID: 29345311
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes.
Frühbeck G; Gómez-Ambrosi J; Ramírez B; Becerril S; Rodríguez A; Mentxaka A; Valentí V; Moncada R; Reina G; Baixauli J; Casado M; Silva C; Escalada J; Catalán V
Cell Mol Life Sci; 2024 Feb; 81(1):77. PubMed ID: 38315242
[TBL] [Abstract][Full Text] [Related]
4. Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Rotellar F; Valentí V; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1880-9. PubMed ID: 22851489
[TBL] [Abstract][Full Text] [Related]
5. Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress.
Frühbeck G; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Valentí V; Moncada R; Becerril S; Unamuno X; Silva C; Salvador J; Catalán V
Metabolism; 2018 Oct; 87():123-135. PubMed ID: 29679615
[TBL] [Abstract][Full Text] [Related]
6. Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes.
Kim Y; Wang W; Okla M; Kang I; Moreau R; Chung S
J Lipid Res; 2016 Jan; 57(1):66-76. PubMed ID: 26628639
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane reduces pro-inflammatory response to palmitic acid in monocytes and adipose tissue macrophages.
Williams EJ; Guilleminault L; Berthon BS; Eslick S; Wright T; Karihaloo C; Gately M; Baines KJ; Wood LG
J Nutr Biochem; 2022 Jun; 104():108978. PubMed ID: 35271969
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia.
de Jesus JCR; Murari ASP; Radloff K; de Moraes RCM; Figuerêdo RG; Pessoa AFM; Rosa-Neto JC; Matos-Neto EM; Alcântara PSM; Tokeshi F; Maximiano LF; Bin FC; Formiga FB; Otoch JP; Seelaender M
Front Immunol; 2021; 12():729182. PubMed ID: 34630405
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis.
Chen Z; Zhong H; Wei J; Lin S; Zong Z; Gong F; Huang X; Sun J; Li P; Lin H; Wei B; Chu J
Arthritis Res Ther; 2019 Dec; 21(1):300. PubMed ID: 31870428
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases.
Wu KK; Cheung SW; Cheng KK
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545355
[TBL] [Abstract][Full Text] [Related]
12. The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation.
Molyvdas A; Georgopoulou U; Lazaridis N; Hytiroglou P; Dimitriadis A; Foka P; Vassiliadis T; Loli G; Phillipidis A; Zebekakis P; Germenis AE; Speletas M; Germanidis G
Cytokine; 2018 Oct; 110():389-396. PubMed ID: 29803661
[TBL] [Abstract][Full Text] [Related]
13. Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study.
Zhu X; Lin X; Zhang P; Liu Y; Ling W; Guo H
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101843. PubMed ID: 34922061
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
[TBL] [Abstract][Full Text] [Related]
15. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
Liu J; Wang T; He K; Xu M; Gong JP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
[TBL] [Abstract][Full Text] [Related]
16. Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation.
Qiu Q; Yang Z; Cao F; Yang C; Hardy P; Yan X; Yang S; Xiong W
Exp Cell Res; 2020 Jan; 386(2):111737. PubMed ID: 31759058
[TBL] [Abstract][Full Text] [Related]
17. A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling.
Healy NP; Kirwan AM; McArdle MA; Holohan K; Nongonierma AB; Keane D; Kelly S; Celkova L; Lyons CL; McGillicuddy FC; Finucane OM; Murray BA; Kelly PM; Brennan L; FitzGerald RJ; Roche HM
Mol Nutr Food Res; 2016 Nov; 60(11):2421-2432. PubMed ID: 27390025
[TBL] [Abstract][Full Text] [Related]
18. Role of ASM/Cer/TXNIP signaling module in the NLRP3 inflammasome activation.
Jiang J; Shi Y; Cao J; Lu Y; Sun G; Yang J
Lipids Health Dis; 2021 Feb; 20(1):19. PubMed ID: 33612104
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effects of Toll-Like Receptor 4, NLRP3 Inflammasome, and Interleukin-1β on White Adipocyte Browning.
Okla M; Zaher W; Alfayez M; Chung S
Inflammation; 2018 Mar; 41(2):626-642. PubMed ID: 29264745
[TBL] [Abstract][Full Text] [Related]
20. The complex P2X7 receptor/inflammasome in perivascular fat tissue of heavy smokers.
Rossi C; Santini E; Chiarugi M; Salvati A; Comassi M; Vitolo E; Madec S; Solini A
Eur J Clin Invest; 2014; 44(3):295-302. PubMed ID: 24372548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
